• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[德国风湿病与临床免疫学协会(DGRh)与新冠疫情]

[The German Society for Rheumatology and Clinical Immunology (DGRh) and the COVID-19 pandemic].

作者信息

Voormann Anna Julia, Specker Christof

机构信息

Deutsche Gesellschaft für Rheumatologie und Klinische Immunologie e. V., Wilhelmine-Gemberg-Weg 6, Aufgang C, 10179, Berlin, Deutschland.

Klinik für Rheumatologie und Klinische Immunologie, Evangelisches Krankenhaus, Kliniken Essen-Mitte, Pattbergstr. 2, 45239, Essen, Deutschland.

出版信息

Z Rheumatol. 2024 Sep;83(7):520-527. doi: 10.1007/s00393-024-01540-9. Epub 2024 Jul 15.

DOI:10.1007/s00393-024-01540-9
PMID:39007934
Abstract

The pandemic led to a global disruption of public life unprecedented in modern times due to an infectious disease, which certainly caused additional special burdens for patients with chronic diseases as well as for personnel in the healthcare system. The German Society of Rheumatology and Clinical Immunology (DGRh), with its Executive Board and two ad hoc commissions, responded promptly to the complex challenges posed by the pandemic for rheumatological care in Germany with provision of a comprehensive and professionally sound range of information and provided concrete assistance in many situations. The diverse activities of the DGRh in the context of the pandemic led to national and international attention and consideration of its committees and recommendations in national committees and guidelines.

摘要

这场大流行导致现代史上因传染病而出现前所未有的全球公共生活混乱,这无疑给慢性病患者以及医疗系统工作人员带来了额外的特殊负担。德国风湿病与临床免疫学协会(DGRh)及其执行委员会和两个特别委员会迅速应对了大流行给德国风湿病护理带来的复杂挑战,提供了全面且专业合理的信息,并在许多情况下提供了具体帮助。DGRh在大流行背景下开展的各种活动引起了国内和国际的关注,其委员会和建议也在国家委员会和指南中得到了考虑。

相似文献

1
[The German Society for Rheumatology and Clinical Immunology (DGRh) and the COVID-19 pandemic].[德国风湿病与临床免疫学协会(DGRh)与新冠疫情]
Z Rheumatol. 2024 Sep;83(7):520-527. doi: 10.1007/s00393-024-01540-9. Epub 2024 Jul 15.
2
[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024].[德国的风湿病护理:德国风湿病与临床免疫学协会2024年备忘录]
Z Rheumatol. 2024 Aug;83(Suppl 2):249-284. doi: 10.1007/s00393-024-01539-2. Epub 2024 Aug 13.
3
[SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].[严重急性呼吸综合征冠状病毒2与风湿性疾病:严重急性呼吸综合征冠状病毒2大流行对炎性风湿性疾病患者的影响。风湿学会行动建议与不同抗风湿治疗风险评估的比较]
Z Rheumatol. 2020 Sep;79(7):686-691. doi: 10.1007/s00393-020-00878-0. Epub 2020 Aug 26.
4
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].[德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下炎症性风湿性疾病患者管理的建议 - 2020年7月更新]
Z Rheumatol. 2020 Sep;79(7):679-685. doi: 10.1007/s00393-020-00851-x.
5
[Statement of the German Society for Rheumatology (DGRh) on the use of video consultations in rheumatology].[德国风湿病学会(DGRh)关于风湿病视频会诊使用的声明]
Z Rheumatol. 2020 Dec;79(10):1078-1085. doi: 10.1007/s00393-020-00932-x. Epub 2020 Nov 17.
6
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].[德国风湿病学会关于SARS-CoV-2/新冠疫情期间风湿病患者护理的当前指南]
Z Rheumatol. 2020 May;79(4):385-388. doi: 10.1007/s00393-020-00799-y.
7
[Corona pandemic in the practice : A flashback and reflection from the rheumatological practice].[实践中的新冠疫情:风湿病学实践的回顾与反思]
Z Rheumatol. 2021 Nov;80(9):795-800. doi: 10.1007/s00393-021-01110-3. Epub 2021 Oct 7.
8
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.德国风湿病学会关于在2019冠状病毒病时期照顾炎性风湿性疾病患者的更新建议——方法、关键信息及论证依据
Rheumatology (Oxford). 2021 May 14;60(5):2128-2133. doi: 10.1093/rheumatology/keab072.
9
[Recommendations of the Laboratory Commission of the German Society of Rheumatology (DGRh) on further training of rheumatologists in the field of rheumatological and immunological laboratory diagnostics].[德国风湿病学会(DGRh)实验室委员会关于风湿病和免疫实验室诊断领域风湿病学家进一步培训的建议]
Z Rheumatol. 2012 Jun;71(4):328-9. doi: 10.1007/s00393-012-0976-x.
10
[Report of the DGRh (German Society for Rheumatology)].[德国风湿病学会(DGRh)报告]
Z Rheumatol. 2011 Jul;70(5):441-3. doi: 10.1007/s00393-011-0835-1.

本文引用的文献

1
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.接种过两剂和三剂疫苗的炎症性风湿病患者中 SARS-CoV-2 突破性感染的特征和结局。
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2023-002998.
2
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD.TNFi 与良好的结果相关,但 JAKi 和利妥昔单抗与 RMD 患者 SARS-CoV-2 感染的不良结果相关。
RMD Open. 2021 Oct;7(3). doi: 10.1136/rmdopen-2021-001896.
3
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].
[德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下照顾炎性风湿性疾病患者的最新建议,包括COVID-19疫苗接种建议]
Z Rheumatol. 2021 Aug;80(6):570-587. doi: 10.1007/s00393-021-01056-6.
4
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.年龄较大、合并症、糖皮质激素的使用和疾病活动度是炎症性风湿和肌肉骨骼疾病患者 COVID-19 住院的危险因素。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001464.
5
[Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients].[炎症性风湿性疾病中针对严重急性呼吸综合征冠状病毒2的疫苗接种:德国风湿病学会给医生和患者的建议]
Z Rheumatol. 2021 Feb;80(1):43-44. doi: 10.1007/s00393-020-00955-4. Epub 2021 Jan 12.
6
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].[德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下炎症性风湿性疾病患者管理的建议 - 2020年7月更新]
Z Rheumatol. 2020 Sep;79(7):679-685. doi: 10.1007/s00393-020-00851-x.
7
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab.接受利妥昔单抗治疗的炎症性风湿疾病患者发生重症新型冠状病毒肺炎的风险增加。
Ann Rheum Dis. 2021 May;80(5):e67. doi: 10.1136/annrheumdis-2020-218075. Epub 2020 Jun 26.
8
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].[德国风湿病学会关于SARS-CoV-2/新冠疫情期间风湿病患者护理的当前指南]
Z Rheumatol. 2020 May;79(4):385-388. doi: 10.1007/s00393-020-00799-y.